| 07:28 PM |
Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And
Nine Months Ended December 31, 2025.
|
| 06:28 PM |
Newspaper Advertisement
|
| 04:45 PM |
Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025.
|
| 09:26 AM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 12:04 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 04:05 PM |
Closure of Trading Window
|
| 12:37 PM |
Disclosure under Regulation 30A of LODR
|
| 06:25 PM |
Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
|
| 01:41 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 11:34 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 11:31 AM |
Exclusive Supply And Marketing Agreement With Cipla Limited For Certain Products.
|
| 03:37 PM |
Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And Half Year
Ended September 30, 2025
|
| 05:44 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 05:40 PM |
Closure of Trading Window
|
| 05:04 PM |
Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30, 2025 Held Today, August 13, 2025
|
| 04:58 PM |
Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30, 2025 Held Today, August 13, 2025
|
| 07:20 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 07:06 PM |
Launch Of Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) I.P., 20 - Valent (PCV20)
|
| 06:00 PM |
Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter Ended June 30, 2025
|
| 07:39 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
|
| 07:23 PM |
Shareholder Meeting / Postal Ballot-Outcome of AGM
|
| 07:38 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 08:35 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 09:21 PM |
Letter To Shareholders Providing The Weblink For Accessing The Annual Report.
|
| 06:30 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:10 PM |
Closure of Trading Window
|
| 01:21 PM |
Compliances-Reg.24(A)-Annual Secretarial Compliance
|
| 10:53 PM |
Appointment Of Cost And Secretarial Auditor
|
| 10:49 PM |
Intimation Of Date Of Annual General Meeting
|
| 10:42 PM |
Corporate Action-Board approves Dividend
|
| 10:27 PM |
Board Meeting Outcome for Outcome Of Board Meeting
|
| 10:24 PM |
Board Meeting Intimation for Board Meeting To Consider And Approve The Audited Financial Results For The Quarter And Financial Year Ended March 31, 2025.
|
| 08:26 PM |
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
|
| 05:55 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 07:06 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 05:00 PM |
Closure of Trading Window
|
| 08:47 PM |
Update On Transfer And Assignment Of Pfizer'S Unexpired Leasehold Rights In The Land Situated At Plot No. 16, Trans Thane Creek Industrial Area, Turbhe, Thane And Sale Of
Structures And Buildings Constructed Thereon, To Zoetis Pharmaceutical Research Private Limited
|
| 12:18 PM |
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
|
| 02:07 PM |
Board Meeting Outcome for Marketing And Supply Agreement With Mylan Pharmaceuticals Private Limited
|
| 12:00 PM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 05:40 PM |
Receipt Of GST Order Levying Tax Demand And Penalty
|
| 10:46 AM |
Receipt Of GST Order Levying Tax Demand And Penalty
|
| 11:44 AM |
Receipt Of GST Order For A Tax Demand, Interest And Penalty
|
| 09:48 PM |
Levy Of Tax Demand And Penalty
|
| 01:38 PM |
Integrated Filing (Financial)
|
| 11:44 AM |
Update On Transfer And Assignment Of Pfizer'S Unexpired Leasehold Rights In The Land Situated At Plot No. 16, Trans Thane Creek Industrial Area, Turbhe, Thane To Zoetis Pharmaceutical Research Private Limited.
|
| 07:06 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 05:04 PM |
Board Meeting Outcome for Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2024
|
| 11:29 PM |
Board Meeting Intimation for Board Meeting To Consider And Take On Record The Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2024
|
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback